117 related articles for article (PubMed ID: 33397842)
41. The COVID-19 pandemic may be receding but the diabetes pandemic rages on.
Mulder H; Fall T
Diabetologia; 2022 Jun; 65(6):915-916. PubMed ID: 35294579
[No Abstract] [Full Text] [Related]
42. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19.
Boccardi V
Nat Rev Endocrinol; 2021 Mar; 17(3):189. PubMed ID: 33452491
[No Abstract] [Full Text] [Related]
43. Effect of Digital Health Among People With Type 2 Diabetes Mellitus During the COVID-19 Pandemic in Japan.
Sankoda A; Waki K; Yamaguchi S; Mieno M; Nangaku M; Yamauchi T; Ohe K
J Diabetes Sci Technol; 2022 Jan; 16(1):256-258. PubMed ID: 34632810
[No Abstract] [Full Text] [Related]
44. Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S.
Kim D; Alshuwaykh O; Sandhu KK; Dennis BB; Cholankeril G; Ahmed A
Diabetes Care; 2022 Jun; 45(6):e107-e109. PubMed ID: 35446372
[No Abstract] [Full Text] [Related]
45. Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic.
Giorda CB; Picariello R; Landriscina T; Tartaglino B; Nada E; Doglio M; Romeo F; Gnavi R
Acta Diabetol; 2022 Jun; 59(6):861-864. PubMed ID: 35182231
[No Abstract] [Full Text] [Related]
46. COVID-19 and Diabetes: The Tale of Two Pandemics.
Littlejohn E; Schein R
Pediatr Ann; 2024 Jul; 53(7):e242-e243. PubMed ID: 38949872
[No Abstract] [Full Text] [Related]
47. Statin use in patients with diabetes amid COVID-19 pandemic.
Kow CS; Ramachandram DS; Hasan SS
Diabetes Metab; 2022 Jan; 48(1):101298. PubMed ID: 34710617
[No Abstract] [Full Text] [Related]
48. Expert suggestion for diabetes management during the recent COVID-19 pandemic.
Wang W; Liu J; Zhang Y; Ning G
J Diabetes; 2022 Jul; 14(7):485-487. PubMed ID: 35842915
[No Abstract] [Full Text] [Related]
49. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
[No Abstract] [Full Text] [Related]
50. Factors Associated With Discontinuation of Subspecialty Diabetes Care During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study.
Haynes SC; Kompala T; Tancredi DJ; Neinstein AB; Crossen SS
Diabetes Care; 2022 Feb; 45(2):e34-e36. PubMed ID: 35020822
[No Abstract] [Full Text] [Related]
51. Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.
Maahs DM; Alonso GT; Gallagher MP; Ebekozien O
Diabetes Care; 2021 May; 44(5):e102. PubMed ID: 33972320
[No Abstract] [Full Text] [Related]
52. Diabetes is not associated with COVID-19-related mortality in older institutionalized people.
Legris P; Vaillard L; Nonciaux C; Hourdain P; Taroux M; Petit JM; Vergès B; Bouillet B
Diabetes Metab; 2021 May; 47(3):101235. PubMed ID: 33515718
[No Abstract] [Full Text] [Related]
53. Trends in Diabetes Care during the COVID-19 Outbreak in Japan: an Observational Study.
Ikesu R; Miyawaki A; Sugiyama T; Nakamura M; Ninomiya H; Kobayashi Y
J Gen Intern Med; 2021 May; 36(5):1460-1462. PubMed ID: 33469742
[No Abstract] [Full Text] [Related]
54. Diabetes and COVID-19: A Tale of 2 Pandemics.
Rizvi AA; Janez A; Al Mahmeed W; Rizzo M
J Cardiovasc Pharmacol; 2021 Jul; 78(1):e1-e2. PubMed ID: 34173808
[No Abstract] [Full Text] [Related]
55. Covid-19 and Diabetes Mellitus.
Attri B; Gupta Y; Tandon N
Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
[No Abstract] [Full Text] [Related]
56. Preexisting prediabetes and the severity of COVID-19.
Sathish T; Cao Y; Kapoor N
Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435
[No Abstract] [Full Text] [Related]
57. Observational research on severe COVID-19 in diabetes.
Stehouwer CDA
Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
[No Abstract] [Full Text] [Related]
58. Unmasking Peripheral Arterial Disease in Diabetic Patients Presenting With Inflammatory Skin Manifestations During the COVID-19 Pandemic.
Georgiadis GS; Argyriou C; Georgakarakos EI; Lazarides MK
Int J Low Extrem Wounds; 2022 Sep; 21(3):344-345. PubMed ID: 33856248
[No Abstract] [Full Text] [Related]
59. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
Dhar SK; Sachdeva K; Das M
Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
[No Abstract] [Full Text] [Related]
60. [Vulnerability and health risks of people with diabetes to COVID-19].
Santillán-García A
Gac Sanit; 2021; 35(6):600-601. PubMed ID: 33551210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
